552 related articles for article (PubMed ID: 27991661)
1. Myotonic dystrophy type 1: role of CCG, CTC and CGG interruptions within DMPK alleles in the pathogenesis and molecular diagnosis.
Santoro M; Masciullo M; Silvestri G; Novelli G; Botta A
Clin Genet; 2017 Oct; 92(4):355-364. PubMed ID: 27991661
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of 5' CCG interruptions in complex DMPK expanded alleles.
Botta A; Rossi G; Marcaurelio M; Fontana L; D'Apice MR; Brancati F; Massa R; G Monckton D; Sangiuolo F; Novelli G
Eur J Hum Genet; 2017 Feb; 25(2):257-261. PubMed ID: 27876818
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetic and clinical characterization of myotonic dystrophy type 1 patients carrying variant repeats within DMPK expansions.
Pešović J; Perić S; Brkušanin M; Brajušković G; Rakočević-Stojanović V; Savić-Pavićević D
Neurogenetics; 2017 Dec; 18(4):207-218. PubMed ID: 28942489
[TBL] [Abstract][Full Text] [Related]
4. Identification, molecular characterization and segregation analysis of a variant
Fontana L; Santoro M; D'Apice MR; Peluso F; Gori G; Morrone A; Novelli G; Dosa L; Botta A
Acta Myol; 2020 Mar; 39(1):13-18. PubMed ID: 32607474
[TBL] [Abstract][Full Text] [Related]
5. Molecular and Clinical Implications of Variant Repeats in Myotonic Dystrophy Type 1.
Peric S; Pesovic J; Savic-Pavicevic D; Rakocevic Stojanovic V; Meola G
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008780
[TBL] [Abstract][Full Text] [Related]
6. Molecular, clinical, and muscle studies in myotonic dystrophy type 1 (DM1) associated with novel variant CCG expansions.
Santoro M; Masciullo M; Pietrobono R; Conte G; Modoni A; Bianchi ML; Rizzo V; Pomponi MG; Tasca G; Neri G; Silvestri G
J Neurol; 2013 May; 260(5):1245-57. PubMed ID: 23263591
[TBL] [Abstract][Full Text] [Related]
7. Fuchs' Endothelial Corneal Dystrophy and RNA Foci in Patients With Myotonic Dystrophy.
Mootha VV; Hansen B; Rong Z; Mammen PP; Zhou Z; Xing C; Gong X
Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4579-4585. PubMed ID: 28886202
[TBL] [Abstract][Full Text] [Related]
8.
Visconti VV; Macrì E; D'Apice MR; Centofanti F; Massa R; Novelli G; Botta A
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373276
[TBL] [Abstract][Full Text] [Related]
9. De novo repeat interruptions are associated with reduced somatic instability and mild or absent clinical features in myotonic dystrophy type 1.
Cumming SA; Hamilton MJ; Robb Y; Gregory H; McWilliam C; Cooper A; Adam B; McGhie J; Hamilton G; Herzyk P; Tschannen MR; Worthey E; Petty R; Ballantyne B; ; Warner J; Farrugia ME; Longman C; Monckton DG
Eur J Hum Genet; 2018 Nov; 26(11):1635-1647. PubMed ID: 29967337
[TBL] [Abstract][Full Text] [Related]
10. A DM1 family with interruptions associated with atypical symptoms and late onset but not with a milder phenotype.
Ballester-Lopez A; Koehorst E; Almendrote M; Martínez-Piñeiro A; Lucente G; Linares-Pardo I; Núñez-Manchón J; Guanyabens N; Cano A; Lucia A; Overend G; Cumming SA; Monckton DG; Casadevall T; Isern I; Sánchez-Ojanguren J; Planas A; Rodríguez-Palmero A; Monlleó-Neila L; Pintos-Morell G; Ramos-Fransi A; Coll-Cantí J; Nogales-Gadea G
Hum Mutat; 2020 Feb; 41(2):420-431. PubMed ID: 31608518
[TBL] [Abstract][Full Text] [Related]
11. Unusual association of a unique CAG interruption in 5' of DM1 CTG repeats with intergenerational contractions and low somatic mosaicism.
Tomé S; Dandelot E; Dogan C; Bertrand A; Geneviève D; Péréon Y; ; Simon M; Bonnefont JP; Bassez G; Gourdon G
Hum Mutat; 2018 Jul; 39(7):970-982. PubMed ID: 29664219
[TBL] [Abstract][Full Text] [Related]
12. Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2.
Ranum LP; Day JW
Curr Neurol Neurosci Rep; 2002 Sep; 2(5):465-70. PubMed ID: 12169228
[TBL] [Abstract][Full Text] [Related]
13. Identification of a CCG-Enriched Expanded Allele in Patients with Myotonic Dystrophy Type 1 Using Amplification-Free Long-Read Sequencing.
Tsai YC; de Pontual L; Heiner C; Stojkovic T; Furling D; Bassez G; Gourdon G; Tomé S
J Mol Diagn; 2022 Nov; 24(11):1143-1154. PubMed ID: 36084803
[TBL] [Abstract][Full Text] [Related]
14. Sense and Antisense DMPK RNA Foci Accumulate in DM1 Tissues during Development.
Michel L; Huguet-Lachon A; Gourdon G
PLoS One; 2015; 10(9):e0137620. PubMed ID: 26339785
[TBL] [Abstract][Full Text] [Related]
15. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1.
de Haro M; Al-Ramahi I; De Gouyon B; Ukani L; Rosa A; Faustino NA; Ashizawa T; Cooper TA; Botas J
Hum Mol Genet; 2006 Jul; 15(13):2138-45. PubMed ID: 16723374
[TBL] [Abstract][Full Text] [Related]
16. Loss of MBNL1-mediated retrograde BDNF signaling in the myotonic dystrophy brain.
Wang PY; Kuo TY; Wang LH; Liang WH; Wang GS
Acta Neuropathol Commun; 2023 Mar; 11(1):44. PubMed ID: 36922901
[TBL] [Abstract][Full Text] [Related]
17. Systemic delivery of a Peptide-linked morpholino oligonucleotide neutralizes mutant RNA toxicity in a mouse model of myotonic dystrophy.
Leger AJ; Mosquea LM; Clayton NP; Wu IH; Weeden T; Nelson CA; Phillips L; Roberts E; Piepenhagen PA; Cheng SH; Wentworth BM
Nucleic Acid Ther; 2013 Apr; 23(2):109-17. PubMed ID: 23308382
[TBL] [Abstract][Full Text] [Related]
18. Myotonic dystrophy type 1 (DM1): a triplet repeat expansion disorder.
Kumar A; Agarwal S; Agarwal D; Phadke SR
Gene; 2013 Jun; 522(2):226-30. PubMed ID: 23570879
[TBL] [Abstract][Full Text] [Related]
19. Fuchs' Endothelial Corneal Dystrophy in Patients With Myotonic Dystrophy, Type 1.
Winkler NS; Milone M; Martinez-Thompson JM; Raja H; Aleff RA; Patel SV; Fautsch MP; Wieben ED; Baratz KH
Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3053-3057. PubMed ID: 30025114
[TBL] [Abstract][Full Text] [Related]
20. Developmental insights into the pathology of and therapeutic strategies for DM1: Back to the basics.
Chau A; Kalsotra A
Dev Dyn; 2015 Mar; 244(3):377-90. PubMed ID: 25504326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
